Gastric antral vascular ectasia: Difference between revisions

Jump to navigation Jump to search
Line 86: Line 86:
GAVE is treated commonly by means of an endoscope, including [[argon plasma coagulation]] and electrocautery. Since endoscopy with argon photocoagulation is "usually effective", surgery is "usually not required."Coagulation therapy is well-tolerated but "tends to induce oozing and bleeding." "Endoscopy with thermal ablation" is favored [[medical treatment]] because of its low side effects and low mortality, but is "rarely curative."
GAVE is treated commonly by means of an endoscope, including [[argon plasma coagulation]] and electrocautery. Since endoscopy with argon photocoagulation is "usually effective", surgery is "usually not required."Coagulation therapy is well-tolerated but "tends to induce oozing and bleeding." "Endoscopy with thermal ablation" is favored [[medical treatment]] because of its low side effects and low mortality, but is "rarely curative."
====Other treatments====
====Other treatments====
Other medical treatments have been tried and include [[estrogen]] and [[progesterone]] therapy, and anti-fibrinolytic drugs such as [[tranexamic acid]]. Corticostreoids are effective, but are "limited by their [[side effects]]."
Other medical treatments have been tried and include [[estrogen]] and [[progesterone]] therapy, and anti-fibrinolytic drugs such as [[tranexamic acid]]. Corticosteroids are effective, but are "limited by their [[side effects]]."


====Treatment of co-morbid conditions====
====Treatment of co-morbid conditions====

Revision as of 15:26, 5 September 2012

Gastric antral vascular ectasia
Endoscopic image of gastric antral vascular ectasia seen as a radial pattern around the pylorus before (top) and after (bottom) treatment with argon plasma coagulation
DiseasesDB 29505
MeSH C06.405.748.280

WikiDoc Resources for Gastric antral vascular ectasia

Articles

Most recent articles on Gastric antral vascular ectasia

Most cited articles on Gastric antral vascular ectasia

Review articles on Gastric antral vascular ectasia

Articles on Gastric antral vascular ectasia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Gastric antral vascular ectasia

Images of Gastric antral vascular ectasia

Photos of Gastric antral vascular ectasia

Podcasts & MP3s on Gastric antral vascular ectasia

Videos on Gastric antral vascular ectasia

Evidence Based Medicine

Cochrane Collaboration on Gastric antral vascular ectasia

Bandolier on Gastric antral vascular ectasia

TRIP on Gastric antral vascular ectasia

Clinical Trials

Ongoing Trials on Gastric antral vascular ectasia at Clinical Trials.gov

Trial results on Gastric antral vascular ectasia

Clinical Trials on Gastric antral vascular ectasia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Gastric antral vascular ectasia

NICE Guidance on Gastric antral vascular ectasia

NHS PRODIGY Guidance

FDA on Gastric antral vascular ectasia

CDC on Gastric antral vascular ectasia

Books

Books on Gastric antral vascular ectasia

News

Gastric antral vascular ectasia in the news

Be alerted to news on Gastric antral vascular ectasia

News trends on Gastric antral vascular ectasia

Commentary

Blogs on Gastric antral vascular ectasia

Definitions

Definitions of Gastric antral vascular ectasia

Patient Resources / Community

Patient resources on Gastric antral vascular ectasia

Discussion groups on Gastric antral vascular ectasia

Patient Handouts on Gastric antral vascular ectasia

Directions to Hospitals Treating Gastric antral vascular ectasia

Risk calculators and risk factors for Gastric antral vascular ectasia

Healthcare Provider Resources

Symptoms of Gastric antral vascular ectasia

Causes & Risk Factors for Gastric antral vascular ectasia

Diagnostic studies for Gastric antral vascular ectasia

Treatment of Gastric antral vascular ectasia

Continuing Medical Education (CME)

CME Programs on Gastric antral vascular ectasia

International

Gastric antral vascular ectasia en Espanol

Gastric antral vascular ectasia en Francais

Business

Gastric antral vascular ectasia in the Marketplace

Patents on Gastric antral vascular ectasia

Experimental / Informatics

List of terms related to Gastric antral vascular ectasia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Watermelon stomach; GAVE

Overview

Gastric antral vascular ectasia is an uncommon cause of chronic gastrointestinal bleeding or iron deficiency anemia. The condition is associated with dilated small blood vessels in the antrum, or the last part of the stomach. It is also called watermelon stomach because streaky long red areas that are present in the stomach may resemble the markings on watermelon[1].

Historical Perspective

The condition was first discovered in 1952, and reported in the literature in 1953.[2] Watermelon disease was first diagnosed by Wheeler et al. in 1979, and definitively described in four living patients by Jabbari et al. only in 1984. As of 2011, the etiology and pathogenesis are still not known.[3] However, there are several competing hypotheses as to various etiologies.

Pathophysiology

GAVE is characterized by dilated capillaries in the lamina propria with fibrin thrombi.

Microscopic Pathology

Micrograph showing gastric antral vascular ectasia. A large spherical, eosinophilic (i.e. pink) fibrin thrombus is seen off-center right. Stomach biopsy. H&E stain.


Asociated Conditions

GAVE is associated with a number of conditions, including

Causes

65% of patients with both cirrhosis and GAVE are male, but a total of 30% have both conditions. The causal connection between cirrhosis and GAVE has not been proven.

A connective tissue disease has been suspected in some cases.

Autoimmunity may have something to do with it,[4] as 25% of all sclerosis patients who had a certain anti-RNA marker have GAVE. RNA autoimmunity has been suspected as a cause or marker since at least 1996.

One theory current since the 1990s focuses on a history of prolapse of the stomach into the small intestine.

Gastrin levels may indicate a hormonal connection. This may be due to vasoactive intestinal peptide and 5-hydroxy-tryptamine.

It is also possible that infection by H. pylori can cause it.

Differentiating Gastric antral vascular ectasia from other Diseases

GAVE should be differentiated from other causes of intestinal bleeding such as

The differential diagnosis is important because treatments are different.

Epidemiology and Demographics

Age

The average age of diagnosis for GAVE is 73 years of age for females, and 68 for males. Patients in their thirties have been found to have GAVE. It becomes more common in women in their eighties, rising to 4% of all such gastrointestinal conditions.

Gender

Women are about twice as often diagnosed with gastric antral vascular ectasia than men. 71% of all cases of GAVE are diagnosed in females.

Diagnosis

Symptoms

Endoscopy

The endoscopic appearance of GAVE is similar to portal hypertensive gastropathy. Dilated capillaries are seen in the endoscopy which resemble the tell-tale watermelon stripes.

Treatment

Medical Therapy

Traditional treatments

GAVE is treated commonly by means of an endoscope, including argon plasma coagulation and electrocautery. Since endoscopy with argon photocoagulation is "usually effective", surgery is "usually not required."Coagulation therapy is well-tolerated but "tends to induce oozing and bleeding." "Endoscopy with thermal ablation" is favored medical treatment because of its low side effects and low mortality, but is "rarely curative."

Other treatments

Other medical treatments have been tried and include estrogen and progesterone therapy, and anti-fibrinolytic drugs such as tranexamic acid. Corticosteroids are effective, but are "limited by their side effects."

Treatment of co-morbid conditions

A transjugular intrahepatic portosystemic shunt (TIPS or TIPSS) procedure is used to treat portal hypertension when that is present as an associated condition. Unfortunately, the TIPSS, which has been used for similar conditions, may cause or exacerbate hepatic encephalopathy.[6][7] TIPSS-related encephalopathy occurs in about 30% of cases, with the risk being higher in those with previous episodes of encephalopathy, higher age, female sex, and liver disease due to causes other than alcohol.[8] The patient, with his or her physician and family, must balance out a reduction in bleeding caused by TIPS with the significant risk of encephalopathy. Various shunts have been shown in a meta-study of 22 studies to be effective treatment to reduce bleeding, yet none have any demonstrated survival advantage.

If there is cirrhosis of the liver that has progressed to liver failure, then lactulose may be prescribed for hepatic encephalopathy, especially for Type C encephalopathy with diabetes. Also, "antibiotics such as neomycin, metronidazole, and rifaximin" may be used effectively to treat the encephalopathy by removing nitrogen-producing bacteria from the gut.

Paracentesis, a medical procedure involving needle drainage of fluid from a body cavity,[9] may be used to remove fluid from the peritoneal cavity in the abdomen for such cases. This procedure uses a large needle, similar to the better-known amniocentesis.

Surgery

Surgery, consisting of excision of part of the lower stomach, also called antrectomy, is another option. Antrectomy is "the resection, or surgical removal, of a part of the stomach known as the antrum."[10] Laparoscopic surgery is possible in some cases, and as of 2003, was a "novel approach to treating watermelon stomach."[11]

A treatment used sometimes is endoscopic band ligation.[12]

In 2010, a team of Japanese surgeons performed a "novel endoscopic ablation of gastric antral vascular ectasia."[13] The experimental procedure resulted in "no complications."[13]

Relapse is possible, even after treatment by argon plasma coagulation and progesterone.[14] In such cases of relapse, surgery may be the only option; in one case that involved "Endoscopic mucosal resection".[15]

Antrectomy or other surgery is used as a last resort for GAVE. The risks of surgery should be considered. It is said that "surgery is the only cure" for GAVE.

References

  1. Suit P, Petras R, Bauer T, Petrini J (1987). "Gastric antral vascular ectasia. A histologic and morphometric study of "the watermelon stomach"". Am J Surg Pathol. 11 (10): 750–7. PMID 3499091.
  2. Rider, JA; Klotz, AP; Kirsner, JB (1953). "Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage". Gastroenterology. 24 (1): 118–23. PMID 13052170.
  3. Tuveri, Massimiliano; Borsezio, Valentina; Gabbas, Antonio; Mura, Guendalina (2007). "Gastric antral vascular ectasia—an unusual cause of gastric outlet obstruction: report of a case". Surgery today. 37 (6): 503–5. doi:10.1007/s00595-006-3430-3. PMID 17522771.
  4. Valdez, BC; Henning, D; Busch, RK; Woods, K; Flores-Rozas, H; Hurwitz, J; Perlaky, L; Busch, H (1996). "A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach disease". Nucleic Acids Research. 24 (7): 1220–4. doi:10.1093/nar/24.7.1220. PMC 145780. PMID 8614622.
  5. Spahr, L; Villeneuve, J-P; Dufresne, M-P; Tasse, D; Bui, B; Willems, B; Fenyves, D; Pomier-Layrargues, G (1999). "Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension". Gut. 44 (5): 739. doi:10.1136/gut.44.5.739. PMC 1727493. PMID 10205216.
  6. Khan S, Tudur Smith C, Williamson P, Sutton R (2006). Khan, Saboor A, ed. "Cochrane Database of Systematic Reviews". Cochrane Database Syst Rev (4): CD000553. doi:10.1002/14651858.CD000553.pub2. PMID 17054131. |chapter= ignored (help)
  7. Saab S, Nieto JM, Lewis SK, Runyon BA (2006). Saab, Sammy, ed. "TIPSS versus paracentesis for cirrhotic patients with refractory ascites". Cochrane Database Syst Rev (4): CD004889. doi:10.1002/14651858.CD004889.pub2. PMID 17054221. |chapter= ignored (help)
  8. Sundaram V, Shaikh OS (2009). "Hepatic encephalopathy: pathophysiology and emerging therapies". Med. Clin. North Am. 93 (4): 819–36, vii. doi:10.1016/j.mcna.2009.03.009. PMID 19577116. Unknown parameter |month= ignored (help)
  9. Template:DorlandsDict
  10. Surgery Encyclopedia website page on Antrectomy. Accessed September 29, 2010.
  11. Sherman, V; Klassen, DR; Feldman, LS; Jabbari, M; Marcus, V; Fried, GM (2003). "Laparoscopic antrectomy: a novel approach to treating watermelon stomach". Journal of the American College of Surgeons. 197 (5): 864. doi:10.1016/S1072-7515(03)00600-8. PMID 14585429.
  12. Wells, C; Harrison, M; Gurudu, S; Crowell, M; Byrne, T; Depetris, G; Sharma, V (2008). "Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation". Gastrointestinal Endoscopy. 68 (2): 231. doi:10.1016/j.gie.2008.02.021. PMID 18533150.
  13. 13.0 13.1 Komiyama, Masae; Fu, K; Morimoto, T; Konuma, H; Yamagata, T; Izumi, Y; Miyazaki, A; Watanabe, S (2010). "A novel endoscopic ablation of gastric antral vascular ectasia". World Journal of Gastrointestinal Endoscopy. 2 (8): 298. doi:10.4253/wjge.v2.i8.298. PMC 2999147. PMID 21160630.
  14. Shibukawa, G; Irisawa, A; Sakamoto, N; Takagi, T; Wakatsuki, T; Imamura, H; Takahashi, Y; Sato, A; Sato, M (2007). "Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis: relapse after endoscopic treatment by argon plasma coagulation". Internal medicine (Tokyo, Japan). 46 (6): 279–83. doi:10.2169/internalmedicine.46.6203. PMID 17379994.
  15. Katsinelos, P; Chatzimavroudis, G; Katsinelos, T; Panagiotopoulou, K; Kotakidou, R; Tsolkas, G; Triantafillidis, I; Papaziogas, B (2008). "Endoscopic mucosal resection for recurrent gastric antral vascular ectasia". VASA. Zeitschrift fur Gefasskrankheiten. Journal for vascular diseases. 37 (3): 289–92. doi:10.1024/0301-1526.37.3.289. PMID 18690599.


Template:WikiDoc Sources